Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Clinical trial NCT00127283 · COMPLETED

Trial details

NCT number: NCT00127283
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Intracerebral Haemorrhage

Start date: 2005-05-01
Primary completion: 2007-01-01
Enrollment: 829

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.